Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer - HOT ABC

Study identifier:NIS-OCZ-FAS-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Reasons for Changing HOrmonal Therapy of Advanced Breast Cancer

Medical condition

Breast Cancer

Phase

-

Healthy volunteers

No

Study drug

-

Sex

Female

Actual Enrollment

234

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jan 2011
Primary Completion Date: 01 Nov 2011
Study Completion Date: 01 Nov 2011

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria